Multiple Intracranial Nocardia brevicatena Abscesses in a Patient with a Previous History of Tuberculosis: A Case Report Authors: Zhaoyang Li, Yuheng Zhang, Xiaoming Zhang, Hongchun Li, Xue Gong, Qian Zhang, Jing Xu, Xiaofeng Cheng, Jinghuan Wang, Tao Wang, Qiuxin Zhang, Qingwu Yang, Chenhao Zhao Published: 2026 ABSTRACT BackgroundNocardia brevicatena (N. brevicatena) is an uncommon cause of brain infections, frequently mistaken for intracranial tuberculosis, especially in patients with a tuberculosis (TB) history, leading to improper treatment. This case report outlines the symptoms, diagnosis, and treatment of a patient with multiple brain abscesses from N. brevicatena after laryngeal TB, highlighting the importance of next-generation sequencing (NGS) for accurate diagnosis.Case PresentationThis report details a 55-year-old man with a history of TB. Symptoms included dizziness, headache, and unsteady gait, with MRI revealing brain nodules and edema. He initially received anti-TB treatment, but it was ineffective. NGS identified N. brevicatena, and TB tests were negative. He was treated with anti-Nocardia drugs (compound sulfamethoxazole tablets (0.96 g, orally twice daily), amikacin sulfate injection (0.6 g, once daily), and imipenem-cilastatin sodium (0.5 g, every 6 hours)), leading to symptom improvement and MRI changes. Symptoms worsened when treatment was paused but resolved within a week of resuming therapy, following 45 days of treatment, the patient fulfilled the discharge criteria. After seven months, the patient fully recovered with normal MRI results.ConclusionIntracranial N. brevicatena infections are frequently misdiagnosed as TB in patients with a TB history. NGS of blood or cerebrospinal fluid accurately detects pathogens, and TB Xpert helps rule out TB. Both are crucial for targeted treatment and better patient outcomes. Introduction Nocardia is a gram-positive opportunistic actinomycete. Nocardial infections of the central nervous system are clinically rare, and the multifocal intracranial subtype is even less frequently encountered, with cases predominantly reported in immunocompromised individuals.1 Insidious onset and atypical clinical manifestations are observed in this disease, and imaging findings are easily misdiagnosed as tuberculosis, fungal abscesses or intracranial tumors, leading to a low early diagnostic rate.2 Rapid disease progression, high mortality, prolonged treatment duration and frequent recurrence are documented, which bring considerable challenges to clinical diagnosis and management. In the present case report, one patient with multifocal intracranial nocardiosis is described. The clinical features, diagnostic procedures and therapeutic regimens are analyzed, so as to provide a reference for the clinical management of similar cases. Case Presentation A 55-year-old male patient with a history of pulmonary tuberculosis (TB) presented with persistent dizziness, paroxysmal severe throbbing headaches primarily localized to the vertex, and an unsteady gait. On admission, the patient’s axillary body temperature was 36.5 °C, and the temperature remained below 37 °C throughout the entire initial hospital stay. A chest computed tomography (CT) scan revealed interstitial changes in both lungs, as well as multiple infections and partial consolidation of lung tissue. Pathological examination confirmed laryngeal TB. An enhanced magnetic resonance imaging (MRI) scan of the head showed multiple nodules in the bilateral parieto-occipital lobes, basal ganglia, left temporal lobe, and pons (Figure 1). These nodules were accompanied by significant cerebral edema. Small, spherical, peripheral, enhancing nodules were observed with extensive perilesional edema (Figure 1A–C). No thin meningeal enhancement was detected. No Cryptococcus was detected in the cerebrospinal fluid (CSF) using three staining methods. Aerobic bacterial culture of CSF performed for 10 consecutive days yielded negative results, with no bacterial or fungal growth observed.Figure 1T1 FLAIR sequence shows a large edematous lesion (A). Images (B and C) (both T1 FLAIR) show multiple abscess lesions. Imaging findings of recurrence after the patient discontinued medication on his own (Images (D–F)). Following the reinstitution of anti-Nocardia therapy, the patient’s symptoms improved significantly, (G–I). On T2 FLAIR sequence (J), the edema is significantly reduced compared to the previous image (A–I). On T1 FLAIR sequences (K and L), the multiple intracranial abscess lesions have disappeared.Composite human brain magnetic resonance imaging scans in axial, sagittal and coronal views with arrows marking multiple intracranial foci.Two arrows are present. One arrow points to a small bright focus near the left side of the brain close to the outer surface. A second arrow points to a bright focus near the midline in the upper central region. The image B showing a human brain magnetic resonance imaging scan in a sagittal view. Two arrows are present. One arrow points to a small round bright focus near the front outer surface of the brain. A second arrow points to a ring-shaped bright focus deeper within the brain. The image C showing a human brain magnetic resonance imaging scan in a coronal view. Three arrows are present. One arrow points to a small round bright focus near the upper left outer surface. A second arrow points to a small round bright focus near the upper central region. A third arrow points to a small round bright focus on the right side of the brain. The image D showing a human brain magnetic resonance imaging scan in an axial view. Two arrows are present. One arrow points to a bright region near the left upper outer surface. A second arrow points to a bright focus near the midline in the upper central region. The image E showing a human brain magnetic resonance imaging scan in a sagittal view. Two arrows are present. One arrow points to a small bright focus near the front outer surface. A second arrow points to a ring-shaped bright focus deeper within the brain. The image F showing a human brain magnetic resonance imaging scan in a coronal view. Three arrows are present. One arrow points to a small bright focus near the upper left outer surface. A second arrow points to a small bright focus near the central region. A third arrow points to a small bright focus on the right side of the brain. The image G showing a human brain magnetic resonance imaging scan in an axial view. Two arrows are present. One arrow points to a bright region near the left upper outer surface. A second arrow points to a bright focus near the lower central region close to the midline. The image H showing a human brain magnetic resonance imaging scan in a sagittal view. Two arrows are present. One arrow points to a small bright focus near the front outer surface. A second arrow points to a small bright focus deeper within the brain. The image I showing a human brain magnetic resonance imaging scan in a coronal view. Two arrows are present. One arrow points to a small bright focus near the upper left outer surface. A second arrow points to a small bright focus near the central region. The image J showing a human brain magnetic resonance imaging scan in an axial view with no arrows. Bright fluid spaces are visible within the brain, with surrounding brain tissue shown around them. The image K showing a human brain magnetic resonance imaging scan in a sagittal view with no arrows. Midline brain anatomy is shown, including the curved midline structure above the brainstem region. The image L showing a human brain magnetic resonance imaging scan in a coronal view with no arrows. Both cerebral hemispheres are shown with central fluid spaces and surrounding brain tissue. T1 FLAIR sequence shows a large edematous lesion (A). Images (B and C) (both T1 FLAIR) show multiple abscess lesions. Imaging findings of recurrence after the patient discontinued medication on his own (Images (D–F)). Following the reinstitution of anti-Nocardia therapy, the patient’s symptoms improved significantly, (G–I). On T2 FLAIR sequence (J), the edema is significantly reduced compared to the previous image (A–I). On T1 FLAIR sequences (K and L), the multiple intracranial abscess lesions have disappeared. Initially, the presence of positive laryngeal TB pathology suggested the possibility of multiple intracranial TB infections. However, TB treatment was ineffective. Subsequent tests were conducted for parasites and fungi. Next-generation sequencing (NGS) of blood and cerebrospinal fluid samples identified Nocardia brevicatena (N. brevicatena) (Figure 2A and B), and the TB Xpert results were negative. This confirmed the presence of multiple intracranial N. brevicatena infections. Meanwhile, we implemented a multidisciplinary team (MDT) consultation approach involving departments including Neurology, Respiratory Medicine, and Clinical Pharmacy. Through this MDT collaboration, we administered symptomatic and supportive treatments to the patient, encompassing dehydration therapy for intracranial hypertension reduction, neuroprotective therapy, nutritional support, targeted analgesia, and maintenance of electrolyte balance. Concurrently, the triple antimicrobial therapy regimen was ultimately determined, consisting of compound sulfamethoxazole tablets (0.96 g, orally twice daily), amikacin sulfate injection (0.6 g, once daily), and imipenem-cilastatin sodium (0.5 g, every 6 hours). Following one week of treatment, the patient’s condition was significantly improved. Upon discharge, the patient independently discontinued the prescribed medication and opted to resume anti-TB treatment. Two months later, the patient’s condition critically deteriorated, characterized by drowsiness, necessitating readmission. On readmission, the patient’s body temperature was 37.2 °C. During the second hospital stay, body temperature exhibited a slightly elevated trend compared with the first admission, with a peak temperature of 38.9 °C documented on the night of September 3, 2024. Concurrently, the patient’s mean heart rate was significantly higher than that recorded at the initial admission, manifesting as a clinical pattern of overall elevated heart rate with relatively low body temperature—defined as temperature–heart rate dissociation, which suggests the possibility of occult shock. An enhanced MRI of the brain revealed multiple nodules located in the bilateral parieto-occipital lobes, basal ganglia, left temporal lobe, and brainstem, accompanied by significant cerebral edema. Compared to the previous imaging, the walls of certain ring-enhanced lesions were thicker, and some lesions had grown larger with an expanded area of surrounding edema (Figure 1D–F). After re-initiating anti-Nocardia therapy——, these symptoms began to subside approximately one week later (Figure 1G–I), and after 45 days of treatment, the patient had achieved sufficient clinical recovery to meet the discharge criteria. Over the subsequent seven-month follow-up, the patient’s clinical symptoms resolved completely, and MRI scans of the brain returned to normal (Figure 1J–L).Figure 2Sequence alignment and identity profile of Nocardia brevicatena detected by NGS. Multiple Mapping: reads aligning to ≥2 microbial species, representing conserved genomic regions (not counted as species-specific sequences); Unique Mapping: reads uniquely aligned to N. brevicatena, the core indicator of pathogen presence; Identity: percentage of base-pair matches to the reference genome, approaching 100% in mapped regions, confirming alignment accuracy. (A) Cerebrospinal fluid (CSF) sample. (B) Peripheral blood sample. The markedly higher number of species-specific sequences in CSF suggests a greater likelihood of primary intracranial nocardiosis.Two mixed area and line graphs showing Nocardia brevicatena read mapping and identity by genome position.The image A showing Nocardia brevicatena. Legend: Multiple mapping, Unique mapping, Identity. X-axis label: Position on the genome (Mbp). X-axis range: 0 to 6.99, with ticks at 0, 1.398, 2.796, 4.194, 5.592, 6.99. Left y-axis label: Number of reads (unit not shown). Left y-axis ticks: 0, 2, 4, 6, 8, 10. Right y-axis label: Identity(percent). Right y-axis range: 0 to 100 with ticks at 0, 20, 40, 60, 80, 100. Data pattern: multiple mapping and unique mapping form frequent peaks across most genome positions, typically between 0 and about 6 to 7 reads, with many small peaks and troughs. Identity stays near 100 percent for most positions and shows repeated narrow drops to near 0 percent at several positions across the genome. The image B showing Nocardia brevicatena. Legend: Multiple mapping, Unique mapping, Identity. X-axis label: Position on the genome (Mbp). X-axis range: 0 to 6.99, with ticks at 0, 1.398, 2.796, 4.194, 5.592, 6.99. Left y-axis label: Number of reads (unit not shown). Left y-axis range: 0 to 5 with ticks at 0, 1, 2, 3, 4, 5. Right y-axis label: Identity(percent). Right y-axis range: 0 to 100 with ticks at 0, 20, 40, 60, 80, 100. Data pattern: multiple mapping and unique mapping are mostly at 0 reads, with occasional isolated spikes reaching about 1 read. Identity is at 0 percent for most positions and shows several narrow spikes reaching near 100 percent at discrete genome positions. Relationship between A and B: both graphs use the same genome position scale and the same three measures, allowing comparison of denser read coverage and frequent identity drops in A versus sparse read spikes and isolated identity spikes in B. Sequence alignment and identity profile of Nocardia brevicatena detected by NGS. Multiple Mapping: reads aligning to ≥2 microbial species, representing conserved genomic regions (not counted as species-specific sequences); Unique Mapping: reads uniquely aligned to N. brevicatena, the core indicator of pathogen presence; Identity: percentage of base-pair matches to the reference genome, approaching 100% in mapped regions, confirming alignment accuracy. (A) Cerebrospinal fluid (CSF) sample. (B) Peripheral blood sample. The markedly higher number of species-specific sequences in CSF suggests a greater likelihood of primary intracranial nocardiosis. Discussion and Conclusions Nocardia spp. are opportunistic pathogens mainly causing lung infections,3 but they can also affect the skin, soft tissues, and CNS, with CNS nocardiosis having a 22.8% mortality rate.4–6 Nocardia farcinica is the most common species, while Nocardia brevicatena is rare,3,5,7 with few cases reported.8 Nocardia brevicatena, part of the N. brevicatena/N. paucivorans complex (including type II drug susceptibility pattern), as one of the six major pathogenic complexes within the genus Nocardia, cannot break down casein, xanthine, tyrosine, or hypoxanthine and only uses trehalose as a carbon source. It is distinguished from N. paucivorans by its ability to utilize isoamyl alcohol and 1,2-propanediol, as confirmed by DNA–DNA hybridization.9–12 The susceptibility pattern R(resistance)S(susceptibility)SR to gentamicin, tobramycin, amikacin, and erythromycin further differentiates N. brevicatena from other Nocardia species.11 This document presents the first case of multiple intracranial N. brevicatena infection alongside Mycobacterium tuberculosis coinfection, offering potential insights for improving diagnosis and treatment of N. brevicatena infections. A definitive diagnosis was crucial for this case. Considering the patient’s history of laryngeal and pulmonary tuberculosis, cerebral tuberculoma was a key differential diagnosis. Active tuberculosis was ruled out due to negative acid-fast bacilli results in CSF and sputum cultures. Brain abscess was excluded through bacterial cultures of CSF and blood. Cranial MRI and parasitic antibody tests helped rule out parasitic intracranial infections. Intracranial tumors were preliminarily excluded using tumor marker detection. The presence of interstitial pneumonia and pulmonary infection, shown as patchy and honeycomb-like opacities in both lungs, required linking to the patient’s long-term dust exposure and pulmonary alveolar proteinosis. Given the patient’s history of tuberculosis, a multifactorial cause is possible. No immunodeficiency disorders or immunosuppressive treatments were found, suggesting that impaired immunity from previous lung injury might be a mechanism for the co-infection. As an emerging sequencing modality, NGS presents irreplaceable value in the diagnosis of infectious diseases, particularly for the identification of rare, novel, or non-culturable pathogens, thereby providing a more comprehensive and innovative perspective on microbial communities than conventional culture methods.13 Compared with conventional culture approaches, NGS exhibits distinct advantages for the diagnosis of nocardiosis in terms of turnaround time, diagnostic accuracy, and the detection of mixed infections.14–18 Despite its rapid, broad, efficient, and robust detection capabilities,19–23 the limitations of NGS warrant considerable attention. These limitations include, but are not limited to, potential nucleic acid contamination, sophisticated data interpretation workflows, and challenges in the identification of antimicrobial resistance genes; furthermore, the longstanding conundrum of distinguishing colonizing agents from pathogenic pathogens remains unresolved.13,24,25 N. brevicatena is an uncommon pathogen that causes brain infections. Early diagnosis is challenging in patients with a history of TB and N. brevicatena brain infection because detecting the pathogen in brain infections is difficult. This can potentially lead to a misdiagnosis of brain TB. NGS of blood and cerebrospinal fluid testing can identify the pathogen, and TB Xpert can help rule out TB infection, aiding in the diagnosis and treatment of N. brevicatena infections.26